Immunology and Microbiology
T Cell
100%
Immunity
82%
Immunosenescence
61%
Lymphocyte
54%
Adipose Tissue
51%
Exercise
45%
B Cell
45%
CD8
43%
Natural Killer Cell
38%
Cytomegalovirus
36%
Aerobic Exercise
34%
Immunocompetent Cell
33%
Physical Activity
29%
Oxidative Stress
26%
Effector Cell
25%
Lifespan
24%
CD4
24%
Immunology
24%
Cytotoxic T-Cell
24%
Endurance Training
23%
Epstein Barr Virus
22%
Monoclonal Antibody
20%
Complement Component C1q
19%
Complement Dependent Cytotoxicity
19%
Exercise Intensity
19%
T-Helper Cell
18%
Blood Plasma
18%
Monoclonal Antibody Therapy
17%
Lymphocytopenia
16%
Normal Human
16%
Cytomegalovirus Infection
16%
Immune System
14%
Memory B Cell
14%
Mitogen
13%
Daratumumab
13%
Rituximab
13%
Leukocyte
13%
Immunoglobulin Producing Cell
13%
Cancer Cell
12%
Memory T Cell
12%
Blood Group A Antigen
12%
HLA-DR
12%
Target Cell
12%
Immunosurveillance
12%
Leukemia Cell
11%
Antibody-Dependent Cell-Mediated Cytotoxicity
11%
Modified Vaccinia Ankara
11%
Plasmacytoid Dendritic Cell
11%
Virus Capsid Antigen
11%
Respiratory Burst
11%
Medicine and Dentistry
Physical Activity
79%
Malignant Neoplasm
43%
Breast Cancer
39%
Lymphocyte
34%
Hematological Cancer
34%
Adipose Tissue
29%
Immunosenescence
29%
Cancer Therapy
28%
Immunology
28%
T Cell
27%
Endurance Training
23%
Randomized Controlled Trial
22%
Exercise
22%
Physical Inactivity
22%
Disease
20%
Complement Component C1q
19%
Monoclonal Antibody
19%
Complement Dependent Cytotoxicity
19%
Biological Marker
18%
Immune Function
18%
Immunity
18%
B Cell
17%
Monoclonal Antibody Therapy
17%
Immunocompetent Cell
16%
Caloric Intake
15%
In Vitro
14%
Quality of Life
13%
Cancer Cell
12%
Target Cell
12%
Human Physiology
11%
Peroxiredoxin 2
11%
Rheumatoid Arthritis
11%
Phenomics
11%
Complement
11%
Immunometabolism
11%
Lymphocytosis
11%
Lymphocytopenia
11%
Patient Experience
11%
Antioxidant Enzyme
11%
Public Health
11%
Immunomodulation
11%
Spinal Cord Injury
11%
Pandemic
11%
Cytomegalovirus
11%
Energy Expenditure
11%
Infection
11%
COVID-19
11%
Inflammatory Arthritis
11%
Cancer Cell Line
11%
B-Cell Chronic Lymphocytic Leukemia
11%